Holen Sie sich die Stockscreener-App
2.58
3.06%
-0.05
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
NRX Pharmaceuticals Soars 6.88% on FDA Fast Track Designation - AInvest
FDA grants fast track designation for NRx’s depression treatment - Investing.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine) - The Manila Times
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded - GlobeNewswire
13M Americans Consider Suicide Yearly: NRx's Fast-Tracked Ketamine Treatment Now Available - Stock Titan
Has NRx Pharmaceuticals Inc. Equity Warrant formed a bullish divergence2025 Performance Recap & High Accuracy Trade Alerts - Newser
Evaluating NRx Pharmaceuticals Inc. with trendline analysisPortfolio Risk Summary & Stock Market Timing Techniques - Newser
NRx Pharmaceuticals Inc. Equity Warrant stock outlook for YEAR2025 Bull vs Bear & Daily Entry Point Trade Alerts - Newser
Is NRx Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - Newser
Using data tools to time your NRx Pharmaceuticals Inc. exitJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - Newser
NRx Pharmaceuticals Inc. stock trend outlook and recovery path2025 Market Trends & Long-Term Growth Stock Strategies - Newser
Statistical indicators supporting NRx Pharmaceuticals Inc.’s strengthInsider Selling & Free Daily Entry Point Trade Alerts - Newser
Analyzing NRx Pharmaceuticals Inc. Equity Warrant with multi timeframe chartsMarket Growth Report & Daily Market Momentum Tracking - Newser
Is NRx Pharmaceuticals Inc. building a consolidation baseTrade Performance Summary & AI Forecast for Swing Trade Picks - Newser
Can swing trading help recover from NRx Pharmaceuticals Inc. lossesPortfolio Gains Summary & Breakout Confirmation Alerts - Newser
Why NRx Pharmaceuticals Inc. is moving todayEntry Point & Community Trade Idea Sharing Platform - Newser
NRx Pharmaceuticals Inc. Matches Institutional Buying Filter getLinesFromResByArray error: size == 0 - kangso.co.kr
Comparing NRx Pharmaceuticals Inc. in custom built stock radarsWeekly Stock Report & Free High Return Stock Watch Alerts - Newser
NRx Pharmaceuticals Inc. Equity Warrant stock daily chart insightsPortfolio Value Report & Risk Controlled Swing Alerts - Newser
Will NRx Pharmaceuticals Inc. price bounce be sustainable2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
Identifying reversal signals in NRx Pharmaceuticals Inc.July 2025 Review & Accurate Intraday Trade Tips - Newser
What recovery options are there for NRx Pharmaceuticals Inc. Equity Warrant2025 Short Interest & Capital Efficiency Focused Ideas - Newser
How to escape a deep drawdown in NRx Pharmaceuticals Inc.Risk Management & Expert Approved Momentum Trade Ideas - Newser
How hedge fund analytics apply to NRx Pharmaceuticals Inc. Equity Warrant stock2025 Earnings Impact & Step-by-Step Trade Execution Guides - Newser
Relative strength of NRx Pharmaceuticals Inc. Equity Warrant in sector analysis - Newser
Can technical indicators confirm NRx Pharmaceuticals Inc. Equity Warrant’s reversalJuly 2025 Update & Real-Time Chart Pattern Alerts - Newser
NRx Pharmaceuticals files $150M mixed shelf offering - MSN
Should you hold or exit NRx Pharmaceuticals Inc. Equity Warrant nowEarnings Recap Summary & Growth-Oriented Investment Plans - Newser
Volume Surge May Signal Institutional Interest in NRx Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
NRx Pharmaceuticals: A Modern Solution to Centuries-Old Problem of Depression and Suicide Ideation - AInvest
NRx Pharmaceuticals' Approach To Treating Depression And Suicide Ideation Brings Modern Solution To Centuries-Old Problem - Nasdaq
Can a trend reversal in NRx Pharmaceuticals Inc. lead to recoveryEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative - Yahoo Finance
Can NRx Pharmaceuticals Inc. ride the EV wave2025 Price Momentum & High Accuracy Trade Alerts - 더경남뉴스
Tick level data insight on NRx Pharmaceuticals Inc. Equity Warrant volatility2025 Market Trends & Community Consensus Stock Picks - Newser
How to recover losses in NRx Pharmaceuticals Inc. Equity Warrant stockBond Market & Long-Term Growth Plans - Newser
Historical volatility pattern of NRx Pharmaceuticals Inc. Equity Warrant visualizedMarket Risk Analysis & Short-Term High Return Ideas - Newser
Automated trading signals detected on NRx Pharmaceuticals Inc. Equity WarrantMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Published on: 2025-08-27 04:29:44 - Newser
Custom strategy builders for tracking NRx Pharmaceuticals Inc.Earnings Risk Summary & Technical Buy Zone Confirmation - Newser
NRx Pharmaceuticals Inc. stock trendline breakdownJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
What to expect from NRx Pharmaceuticals Inc. Equity Warrant in the next 30 daysJuly 2025 Macro Moves & Entry Point Confirmation Signals - Newser
Visual analytics tools that track NRx Pharmaceuticals Inc. Equity Warrant performanceTrade Exit Report & Growth Focused Entry Reports - Newser
Real time social sentiment graph for NRx Pharmaceuticals Inc. Equity WarrantMarket Volume Report & Fast Exit/Entry Strategy Plans - Newser
Is NRx Pharmaceuticals Inc. stock bottoming outGold Moves & Fast Exit Strategy with Risk Control - Newser
Will NRx Pharmaceuticals Inc. outperform its industry peersWeekly Trend Report & Free Safe Capital Growth Stock Tips - theviewers.co.kr
Sentiment Turns Positive on NRx Pharmaceuticals Inc. — Reversal AheadJuly 2025 Movers & Weekly Sector Rotation Insights - beatles.ru
Has NRx Pharmaceuticals Inc. formed a bullish divergenceWeekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
NRx Pharmaceuticals stock price target raised to $34 from $31 at D. Boral Capital - Investing.com
NRX Pharmaceuticals' Price Target Boosted to $34 by D. Boral Capital Analyst. - AInvest
NRX Pharmaceuticals: Buy Rating Maintained with PT Raised to $34. - AInvest
Trend analysis for NRx Pharmaceuticals Inc. this weekInsider Buying & Long Hold Capital Preservation Plans - Newser
NRx Pharmaceuticals Secures Expanded FDA Fast Track Designation and Strategic Investments Amid Growth Plans - MSN
1.46%
7.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):